EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Repurposing Antipsychotics in Cancer Therapy: Modulation of Autophagy Mechanisms

Elahe Orak Sarkani, Sarvenaz Parsa, Sanaz Darash, Zahra Monzavi Chaleshtori, Motahareh Taghizadeh, Sheida Yahyazadeh, Omid Vakili

Clinical Drug Investigation · 2026-09 · 46 (9) · 1009-1029

DOI: 10.1007/s40261-026-01579-3 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Drug Investigation, online erschienen am 02.07.2026. Verfasst von Elahe Orak Sarkani und 6 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Committee, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran. Hauptthemen laut MEDLINE: Autophagy, Antipsychotic Agents, Neoplasms, Drug Repositioning. Die Arbeit nennt 124 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antipsychotic drugs, long established in the management of psychotic disorders, are increasingly recognized as modulators of autophagy with potential implications for cancer therapy. A growing body of evidence demonstrates that several antipsychotics, such as phenothiazines and penfluridol, can regulate autophagic flux in tumor cells, thereby affecting cell survival, apoptotic signaling, and responsiveness to anticancer treatments. Autophagy is a fundamental homeostatic process that enables tumor cells to meet heightened metabolic demands and adapt to diverse cellular stresses; however, its dysregulation can also facilitate therapeutic resistance. Pharmacological modulation of this pathway by antipsychotics may therefore enhance tumor sensitivity to conventional therapies and contribute to overcoming drug resistance. Importantly, the effects of these agents on autophagy are context dependent, varying with drug class, concentration, and tumor type, and can lead to divergent outcomes in tumor growth and progression. Drawing on accumulating preclinical and emerging clinical evidence, the current review delineates the molecular basis of antipsychotic-autophagy crosstalk and highlights the promise of repurposing these agents as adjunctive strategies in cancer treatment, while underscoring the need for rigorous mechanistic and translational investigations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutophagyAntipsychotic AgentsNeoplasmsDrug RepositioningAntineoplastic AgentsHumansAnimals

Substanzen

Antipsychotic AgentsAntineoplastic Agents

Autor:innen und Institutionen

  • Student Research Committee, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Department of Clinical Biochemistry, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Department of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Department of Clinical Biochemistry, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. o.vakili.isf@gmail.com.

Zitieren

APA

Orak Sarkani, E., Parsa, S., Darash, S., Monzavi Chaleshtori, Z., Taghizadeh, M., Yahyazadeh, S., & Vakili, O. (2026). Repurposing Antipsychotics in Cancer Therapy: Modulation of Autophagy Mechanisms. Clinical Drug Investigation, 46(9), 1009-1029. https://doi.org/10.1007/s40261-026-01579-3

Vancouver

Orak Sarkani E, Parsa S, Darash S, Monzavi Chaleshtori Z, Taghizadeh M, Yahyazadeh S, et al. Repurposing Antipsychotics in Cancer Therapy: Modulation of Autophagy Mechanisms. Clinical Drug Investigation. 2026;46(9):1009-1029. doi:10.1007/s40261-026-01579-3

BibTeX
@article{OrakSarkani2026,
  author = {Orak Sarkani, Elahe and Parsa, Sarvenaz and Darash, Sanaz and Monzavi Chaleshtori, Zahra and Taghizadeh, Motahareh and Yahyazadeh, Sheida and Vakili, Omid},
  title = {Repurposing Antipsychotics in Cancer Therapy: Modulation of Autophagy Mechanisms},
  journal = {Clinical Drug Investigation},
  year = {2026},
  volume = {46},
  number = {9},
  pages = {1009--1029},
  doi = {10.1007/s40261-026-01579-3}
}
Kostenlos starten →